Viewing Study NCT02531633


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2026-03-02 @ 4:55 PM
Study NCT ID: NCT02531633
Status: TERMINATED
Last Update Posted: 2019-07-31
First Post: 2015-07-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Giant Cell Arteritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Giant Cell Arteritis, Sirukumab, Prednisone View